{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:27:35Z","timestamp":1761514055729,"version":"3.37.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013927","name":"MPS Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Improved Therapies for MPS I Program"},{"name":"CURE Sanfilippo foundation","award":["NIH T32 HL086344","R43 NS089383"],"award-info":[{"award-number":["NIH T32 HL086344","R43 NS089383"]}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCSD Electron Microscopy Facility"},{"name":"UCSD Shared Microscope Facility"},{"name":"UCSD GRTC GlycoAnalytics Core"},{"name":"NIH Cancer Center","award":["P30 CA23100"],"award-info":[{"award-number":["P30 CA23100"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P41 GM103390"],"award-info":[{"award-number":["P41 GM103390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ymthe.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T19:45:21Z","timestamp":1502739921000},"page":"2743-2752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Guanidinylated Neomycin Conjugation Enhances Intranasal Enzyme Replacement in the Brain"],"prefix":"10.1016","volume":"25","author":[{"given":"Wenyong","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrissa A.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan E.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Hamill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelley W.","family":"Moremen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Sarrazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L.S.M.","family":"Gordts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara E.","family":"Dozier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentry N.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitzhak","family":"Tor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Esko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.08.007_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","article-title":"Order out of chaos: assembly of ligand binding sites in heparan sulfate","volume":"71","author":"Esko","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2017.08.007_bib2","first-page":"3421","article-title":"The mucopolysaccharidoses","volume":"Volume 3","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymthe.2017.08.007_bib3","doi-asserted-by":"crossref","first-page":"46576","DOI":"10.1038\/srep46576","article-title":"Neurodevelopmental changes in excitatory synaptic structure and function in the cerebral cortex of Sanfilippo syndrome IIIA mice","volume":"7","author":"Dwyer","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2017.08.007_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pneurobio.2016.10.002","article-title":"Emerging therapies for neuropathic lysosomal storage disorders","volume":"152","author":"Kelly","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5483\/BMBRep.2015.48.8.101","article-title":"Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases","volume":"48","author":"Oh","year":"2015","journal-title":"BMB Rep."},{"key":"10.1016\/j.ymthe.2017.08.007_bib6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MOP.0b013e32834c20d9","article-title":"Enzyme replacement therapy for lysosomal storage diseases","volume":"23","author":"Lachmann","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.ymthe.2017.08.007_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2017.08.007_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2012.02.006","article-title":"Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration","volume":"106","author":"Wolf","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.08.007_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/mt.2010.78","article-title":"Guanidinylated neomycin mediates heparan sulfate-dependent transport of active enzymes to lysosomes","volume":"18","author":"Sarrazin","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.08.007_bib10","doi-asserted-by":"crossref","first-page":"13585","DOI":"10.1074\/jbc.M700463200","article-title":"Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway","volume":"282","author":"Elson-Schwab","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.08.007_bib11","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/cb400172h","article-title":"Aggregation-mediated macromolecular uptake by a molecular transporter","volume":"8","author":"Inoue","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib12","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1002\/cbic.201000399","article-title":"Cooperative, heparan sulfate-dependent cellular uptake of dimeric guanidinoglycosides","volume":"11","author":"Dix","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ymthe.2017.08.007_bib13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A\u00a0mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymthe.2017.08.007_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.08.007_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ymgme.2013.07.016","article-title":"Glycan-based biomarkers for mucopolysaccharidoses","volume":"111","author":"Lawrence","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.08.007_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.766","article-title":"Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses","volume":"8","author":"Lawrence","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ni1233","article-title":"Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses","volume":"6","author":"Wang","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymthe.2017.08.007_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/10717544.2014.923064","article-title":"Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway","volume":"23","author":"Mustafa","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ymthe.2017.08.007_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/prep.2000.1230","article-title":"Purification and characterization of recombinant human alpha-N-acetylglucosaminidase secreted by Chinese hamster ovary cells","volume":"19","author":"Zhao","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ymthe.2017.08.007_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/prep.2000.1361","article-title":"Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase","volume":"21","author":"Weber","year":"2001","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ymthe.2017.08.007_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.omtm.2017.03.006","article-title":"Engineering of GlcNAc-1-phosphotransferase for production of highly phosphorylated lysosomal enzymes for enzyme replacement therapy","volume":"5","author":"Liu","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2017.08.007_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mt.2008.84","article-title":"Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse","volume":"16","author":"Urayama","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.08.007_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/mrd.1080350415","article-title":"Developmental expression of the IGF-II\/mannose 6-phosphate receptor","volume":"35","author":"Nissley","year":"1993","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.ymthe.2017.08.007_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/0271678X15614589","article-title":"Pharmacologic manipulation of lysosomal enzyme transport across the blood-brain barrier","volume":"36","author":"Urayama","year":"2016","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymthe.2017.08.007_bib26","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1073\/pnas.1214779109","article-title":"Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII","volume":"109","author":"Huynh","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.08.007_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1615\/CritRevImmunol.v24.i3.20","article-title":"From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor","volume":"24","author":"Allavena","year":"2004","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/mt.2008.119","article-title":"Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product","volume":"16","author":"Osborn","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.08.007_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/mt.2013.267","article-title":"Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain","volume":"22","author":"Meng","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.08.007_bib30","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1021\/mp200136x","article-title":"Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein","volume":"8","author":"Boado","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2017.08.007_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/mt.2014.12","article-title":"A Hitchhiker\u2019s guide to the blood-brain barrier: in trans delivery of a therapeutic enzyme","volume":"22","author":"Sands","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.08.007_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.08.007_bib33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ymgme.2011.03.011","article-title":"Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations","volume":"103","author":"Vite","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.08.007_bib34","doi-asserted-by":"crossref","first-page":"14870","DOI":"10.1073\/pnas.1416660111","article-title":"Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB","volume":"111","author":"Kan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.08.007_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.omtm.2017.05.009","article-title":"Clearance of heparan sulfate and attenuation of CNS pathology by intracerebroventricular BMN 250 in Sanfilippo type B mice","volume":"6","author":"Aoyagi-Scharber","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2017.08.007_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","article-title":"Outcomes of hematopoietic stem cell transplantation for Hurler\u2019s syndrome in Europe: a risk factor analysis for graft failure","volume":"40","author":"Boelens","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymthe.2017.08.007_bib37","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymthe.2017.08.007_bib38","doi-asserted-by":"crossref","first-page":"36194","DOI":"10.1074\/jbc.M114.599944","article-title":"Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I","volume":"289","author":"Watson","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.08.007_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/17425247.2015.966682","article-title":"Gene therapy for neurologic manifestations of mucopolysaccharidoses","volume":"12","author":"Wolf","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ymthe.2017.08.007_bib40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1089\/hum.2016.101","article-title":"Delivery of an adeno-associated virus vector into cerebrospinal fluid attenuates central nervous system disease in mucopolysaccharidosis Type II mice","volume":"27","author":"Hinderer","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.08.007_bib41","first-page":"3236","article-title":"Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice","volume":"119","author":"Stanford","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2017.08.007_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.matbio.2013.10.004","article-title":"Heparan sulfate proteoglycan as a cell-surface endocytosis receptor","volume":"35","author":"Christianson","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib43","doi-asserted-by":"crossref","first-page":"a004952","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ymthe.2005.02.031","article-title":"Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice","volume":"12","author":"Orii","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.08.007_bib45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/90242","article-title":"The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors","volume":"19","author":"Xia","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2017.08.007_bib46","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ymthe.2017.08.007_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ymthe.2017.08.007_bib48","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1039\/C6TB01387B","article-title":"Delivery of an active lysosomal enzyme using GNeosomes","volume":"4","author":"Hamill","year":"2016","journal-title":"J.\u00a0Mater. Chem. B Mater. Biol. Med."},{"key":"10.1016\/j.ymthe.2017.08.007_bib49","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1021\/nn507382n","article-title":"GNeosomes: highly lysosomotropic nanoassemblies for lysosomal delivery","volume":"9","author":"Wexselblatt","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2017.08.007_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-neuro-070815-014031","article-title":"Brain disorders due to lysosomal dysfunction","volume":"39","author":"Fraldi","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2017.08.007_bib51","doi-asserted-by":"crossref","first-page":"36283","DOI":"10.1074\/jbc.M112.403360","article-title":"A genetic model of substrate reduction therapy for mucopolysaccharidosis","volume":"287","author":"Lamanna","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2017.08.007_bib52","doi-asserted-by":"crossref","first-page":"16637","DOI":"10.1523\/JNEUROSCI.2452-14.2014","article-title":"Synaptic strength is bidirectionally controlled by opposing activity-dependent regulation of Nedd4-1 and USP8","volume":"34","author":"Scudder","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2017.08.007_bib53","series-title":"Current Protocols in Molecular Biology","first-page":"17.2.1","article-title":"Special considerations for proteoglycans and glycosaminoglycans and their purification","author":"Esko","year":"1993"},{"key":"10.1016\/j.ymthe.2017.08.007_bib54","series-title":"Current Protocols in Molecular Biology","first-page":"17.19.8","article-title":"Measurement of uronic acids","author":"Esko","year":"1996"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617303660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617303660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:47:46Z","timestamp":1589777266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617303660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1525001617303660"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.08.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"type":"print","value":"1525-0016"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guanidinylated Neomycin Conjugation Enhances Intranasal Enzyme Replacement in the Brain","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}